The migraine drug, if approved, could compete very well against existing treatments such as Merck's Maxalt and GlaxoSmithKline's Imitrex.
FORBES: Puff Daddy
For its human trials due to begin this summer Alexza has chosen a generic migraine drug that doesn't have the cardiovascular risks associated with Maxalt or Imitrex.
应用推荐
模块上移
模块下移
不移动